Back to Journals » Therapeutics and Clinical Risk Management » Volume 14 » default

Therapeutics and Clinical Risk Management


Archive: Volume 14, 2018

Ticagrelor – toward more efficient platelet inhibition and beyond

Kubisa MJ, Jezewski MP, Gasecka A, Siller-Matula JM, Postuła M

Therapeutics and Clinical Risk Management 2018, 14:129-140

Published Date: 17 January 2018

Impact of depression on change in coronary heart disease risk status: the Korean Genome and Epidemiology Study (KoGES)

Jang HY, Song YK, Kim JH, Kim MG, Han N, Lee HY, Kim IW, Oh JM

Therapeutics and Clinical Risk Management 2018, 14:121-128

Published Date: 10 January 2018

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis

Vena GA, Cassano N, Iannone F

Therapeutics and Clinical Risk Management 2018, 14:105-116

Published Date: 9 January 2018

Predictors of surgical outcomes after in situ ulnar nerve decompression for cubital tunnel syndrome

Kong L, Bai J, Yu K, Zhang B, Zhang J, Tian D

Therapeutics and Clinical Risk Management 2018, 14:69-74

Published Date: 4 January 2018

Initial peri- and postoperative antibiotic treatment of infected nonunions: results from 212 consecutive patients after mean follow-up of 34 months

Helbig L, Bechberger M, Aldeeri R, Ivanova A, Haubruck P, Miska M, Schmidmaier G, Omlor GW

Therapeutics and Clinical Risk Management 2018, 14:59-67

Published Date: 4 January 2018

European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib

Kawalec P, Śladowska K, Malinowska-Lipień I, Brzostek T, Kózka M

Therapeutics and Clinical Risk Management 2018, 14:15-29

Published Date: 21 December 2017

Examining hemodialyzer membrane performance using proteomic technologies

Bonomini M, Pieroni L, Di Liberato L, Sirolli V, Urbani A

Therapeutics and Clinical Risk Management 2018, 14:1-9

Published Date: 18 December 2017